Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0009 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.001 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |